Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term, Open-label, Non-comparative Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in Paediatric Solid Allograft Recipients

NCT01371344 is registered in ClinicalTrials.gov with Astellas Pharma Europe Ltd. as lead sponsor.

NCT NCT01371344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01371344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term, Open-label, Non-comparative Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in Paediatric Solid Allograft Recipients
Lead sponsor
Astellas Pharma Europe Ltd.
Phase
Phase 4
Overall status
Terminated
Start date
June 24, 2011
Completion date
April 2, 2017
Enrollment
47 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

heart transplantation, kidney transplantation, liver transplantation